📈 Stocks
Goldman-Backed Biotech Attovia Seeks $212.5M in Nasdaq IPO
(13 days ago)
Goldman Sachs-backed biotech firm Attovia is seeking $212.5 million in a US IPO, signaling ongoing appetite for healthcare listings amid cautious equity…